Bacterial activity in cystic fibrosis lung infections
Open Access
- 1 June 2005
- journal article
- Published by Springer Nature in Respiratory Research
- Vol. 6 (1), 49
- https://doi.org/10.1186/1465-9921-6-49
Abstract
Background: Chronic lung infections are the primary cause of morbidity and mortality in Cystic Fibrosis (CF) patients. Recent molecular biological based studies have identified a surprisingly wide range of hitherto unreported bacterial species in the lungs of CF patients. The aim of this study was to determine whether the species present were active and, as such, worthy of further investigation as potential pathogens. Methods: Terminal Restriction Fragment Length Polymorphism (T-RFLP) profiles were generated from PCR products amplified from 16S rDNA and Reverse Transcription Terminal Restriction Fragment Length Polymorphism (RT-T-RFLP) profiles, a marker of metabolic activity, were generated from PCR products amplified from 16S rRNA, both extracted from the same CF sputum sample. To test the level of activity of these bacteria, T-RFLP profiles were compared to RT-T-RFLP profiles. Results: Samples from 17 individuals were studied. Parallel analyses identified a total of 706 individual T-RF and RT-T-RF bands in this sample set. 323 bands were detected by T-RFLP and 383 bands were detected by RT-T-RFLP (statistically significant; P ≤ 0.001). For the group as a whole, 145 bands were detected in a T-RFLP profile alone, suggesting metabolically inactive bacteria. 205 bands were detected in an RT-T-RFLP profile alone and 178 bands were detected in both, suggesting a significant degree of metabolic activity. Although Pseudomonas aeruginosa was present and active in many patients, a low occurrence of other species traditionally considered to be key CF pathogens was detected. T-RFLP profiles obtained for induced sputum samples provided by healthy individuals without CF formed a separate cluster indicating a low level of similarity to those from CF patients. Conclusion: These results indicate that a high proportion of the bacterial species detected in the sputum from all of the CF patients in the study are active. The widespread activity of bacterial species in these samples emphasizes the potential importance of these previously unrecognized species within the CF lung.Keywords
This publication has 30 references indexed in Scilit:
- An ecological perspective on bacterial biodiversityProceedings Of The Royal Society B-Biological Sciences, 2004
- Bacterial Diversity in Cases of Lung Infection in Cystic Fibrosis Patients: 16S Ribosomal DNA (rDNA) Length Heterogeneity PCR and 16S rDNA Terminal Restriction Fragment Length Polymorphism ProfilingJournal of Clinical Microbiology, 2003
- Development of broad-range 16S rDNA PCR for use in the routine diagnostic clinical microbiology serviceJournal of Medical Microbiology, 2003
- Characterization of Unusual Bacteria Isolated from Respiratory Secretions of Cystic Fibrosis Patients and Description of Inquilinus limosus gen. nov., sp. novJournal of Clinical Microbiology, 2002
- Burkholderia cepacia complex: a contraindication to lung transplantation in cystic fibrosis?Transplant Infectious Disease, 2001
- Comparison of conventional and molecular methods for the detection of bacterial pathogens in sputum samples from cystic fibrosis patientsFEMS Immunology & Medical Microbiology, 2000
- Comparison of conventional and molecular methods for the detection of bacterial pathogens in sputum samples from cystic fibrosis patientsFEMS Immunology & Medical Microbiology, 2000
- Clostridium paradoxum DSM 7308T contains multiple 16S rRNA genes with heterogeneous intervening sequencesMicrobiology, 1996
- The incidence of anaerobes in the sputum of patients with cystic fibrosisJournal of Medical Microbiology, 1990
- Mycobacteria possess a surprisingly small number of ribosomal RNA genes in relation to the size of their genomeBiochemical and Biophysical Research Communications, 1986